Physician profile
Lisa A Schultz
NPI 1194816595
$4,385.85
in general payments reported to CMS, 2019-2025
43 companies · $538 in 2025
The $538 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,240 · 2022: $854 · 2023: $971 · 2024: $783 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,292.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $435.49 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $434.77 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $386.73 | 2021-2025 | Jardiance, Tradjenta, Spiriva Respimat |
| Abbvie INC. | $348.88 | 2021-2025 | |
| Novo Nordisk INC | $333.80 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $275.80 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $226.37 | 2021-2025 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $170.36 | 2021-2023 | Eliquis |
| Daiichi Sankyo INC. | $168.73 | 2021-2023 | Injectafer |
| Exact Sciences Corporation | $158.45 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $146.20 | 2021-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $130.21 | 2022-2024 | Xarelto, Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.97 | 2021-2025 | Xifaxan |
| Amarin Pharma, INC. | $80.43 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $66.05 | 2022-2023 | Ztlido |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.